A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1
- 23 April 2008
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (7) , 911-912
- https://doi.org/10.1097/qad.0b013e3282f82b96
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pre-steady-state Kinetic Studies Establish Entecavir 5′-Triphosphate as a Substrate for HIV-1 Reverse TranscriptaseJournal of Biological Chemistry, 2008
- Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naïve patient treated for chronic HBVAIDS, 2007
- Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta virusesAIDS, 2007
- The HBV Drug Entecavir — Effects on HIV-1 Replication and ResistanceNew England Journal of Medicine, 2007
- Early Virologic Failure in HIV-Coinfected Hepatitis C Patients Treated With the Peginterferon-Ribavirin CombinationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007